MRK vs PLUS · P/E 33, rev $65.01B vs P/E 17, rev $2.07B
Merck & Company Inc (MRK) versus ePlus inc (PLUS) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
ePlus inc (PLUS) is a software - application company listed on NASDAQ.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported PLUS revenue for 2025-03-31 was $2.07B. Net income was $108.0M. Revenue was down 7.0% from 2024-03-31 to 2025-03-31. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. PLUS currently screens at market cap $2.10B and trailing P/E 17.1.
Not investment advice. Open the MRK and PLUS stock pages for the full models.
Not investment advice.